Free community. Create a free account to join OppHub America — news, markets, and money angles together. Join free →

Form 4 insider tape

DFTX

Live SEC EDGAR Form 4 buys and sells for DFTX · 0 buys / 5 sells in this slice. Structured filings only — no AI rewrite. Informational — not investment advice.

SellInsider
$DFTXDefinium Therapeutics, Inc.

Karlin Daniel — sell in Definium Therapeutics, Inc.

Officer (Chief Medical Officer), Director

10,853 shares @ $36.57 · ~$397K · code S

View SEC EDGAR filing →
SellInsider
$DFTXDefinium Therapeutics, Inc.

Barrow Robert — sell in Definium Therapeutics, Inc.

Officer (Chief Executive Officer), Director

31,550 shares @ $36.57 · ~$1.2M · code S

View SEC EDGAR filing →
SellInsider
$DFTXDefinium Therapeutics, Inc.

Wiley Matthew T. — sell in Definium Therapeutics, Inc.

Officer (Chief Commercial Officer)

3,097 shares @ $36.57 · ~$113K · code S

View SEC EDGAR filing →
SellInsider
$DFTXDefinium Therapeutics, Inc.

Sullivan Mark — sell in Definium Therapeutics, Inc.

Officer (Chief Legal Officer)

14,051 shares @ $36.57 · ~$514K · code S

View SEC EDGAR filing →
OtherInsider
$DFTXDefinium Therapeutics, Inc.

Vallone Carol A — other in Definium Therapeutics, Inc.

1,086 shares @ $35.52 · ~$39K · code M

View SEC EDGAR filing →
OtherInsider
$DFTXDefinium Therapeutics, Inc.

Krebs Andreas — other in Definium Therapeutics, Inc.

1,629 shares @ $35.52 · ~$58K · code M

View SEC EDGAR filing →
GrantInsider
$DFTXDefinium Therapeutics, Inc.

Karlin Daniel — grant in Definium Therapeutics, Inc.

Chief Medical Officer

200,000 shares · code A

View SEC EDGAR filing →
GrantInsider
$DFTXDefinium Therapeutics, Inc.

Wiley Matthew T. — grant in Definium Therapeutics, Inc.

Chief Commercial Officer

125,000 shares · code A

View SEC EDGAR filing →
GrantInsider
$DFTXDefinium Therapeutics, Inc.

Sullivan Mark — grant in Definium Therapeutics, Inc.

Chief Legal Officer

125,000 shares · code A

View SEC EDGAR filing →
GrantInsider
$DFTXDefinium Therapeutics, Inc.

Roberts Brandi — grant in Definium Therapeutics, Inc.

Chief Financial Officer

125,000 shares · code A

View SEC EDGAR filing →
GrantInsider
$DFTXDefinium Therapeutics, Inc.

Barrow Robert — grant in Definium Therapeutics, Inc.

Chief Executive Officer

750,000 shares · code A

View SEC EDGAR filing →
SellInsider
$DFTXDefinium Therapeutics, Inc.

Barrow Robert — sell in Definium Therapeutics, Inc.

Chief Executive Officer

19,023 shares @ $37.94 · ~$722K · code S

View SEC EDGAR filing →
GrantInsider
$DFTXDefinium Therapeutics, Inc.

Barrow Robert — grant in Definium Therapeutics, Inc.

Chief Executive Officer

375,000 shares · code A

View SEC EDGAR filing →
GrantInsider
$DFTXDefinium Therapeutics, Inc.

Karlin Daniel — grant in Definium Therapeutics, Inc.

Chief Medical Officer

100,000 shares · code A

View SEC EDGAR filing →
GrantInsider
$DFTXDefinium Therapeutics, Inc.

Sullivan Mark — grant in Definium Therapeutics, Inc.

Chief Legal Officer

62,500 shares · code A

View SEC EDGAR filing →
GrantInsider
$DFTXDefinium Therapeutics, Inc.

Wiley Matthew T. — grant in Definium Therapeutics, Inc.

Chief Commercial Officer

62,500 shares · code A

View SEC EDGAR filing →
GrantInsider
$DFTXDefinium Therapeutics, Inc.

Roberts Brandi — grant in Definium Therapeutics, Inc.

Chief Financial Officer

62,500 shares · code A

View SEC EDGAR filing →